trial · primary record
[225Ac]Ac-FL-261
Solid Tumor
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 208 |
| Primary completion | 2030-06-30 |
| Primary endpoint | Phase 1 Dose Escalation: Incidence of Dose-Limiting Toxicities (DLTs) |
| Registry ID | NCT07873450 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:39.933Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07873450
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.